The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C09 | Agents acting on the renin-angiotensin system | |
| 3 | C09D | Angiotensin II antagonists, combinations | |
| 4 | C09DA | Angiotensin II antagonists and diuretics |
| Code | Title | |
|---|---|---|
| C09DA01 | Losartan and diuretics | |
| C09DA02 | Eprosartan and diuretics | |
| C09DA03 | Valsartan and diuretics | |
| C09DA04 | Irbesartan and diuretics | |
| C09DA06 | Candesartan and diuretics | |
| C09DA07 | Telmisartan and diuretics | |
| C09DA08 | Olmesartan medoxomil and diuretics | |
| C09DA09 |
| Active Ingredient | Description | |
|---|---|---|
| Irbesartan and Hydrochlorothiazide |
The combination of irbesartan and hydrochlorothiazide has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone. Irbesartan is a potent, orally active, selective angiotensin-II receptor (AT1 subtype) antagonist. Hydrochlorothiazide is a thiazide diuretic. The combination of hydrochlorothiazide and irbesartan produces dose-related additive reductions in blood pressure across their therapeutic dose ranges. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ATACAND HCT Tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| CO-DIOVAN Film-coated tablet | Pharmaceutical Benefits Scheme (AU) | MPI, EU: SmPC | |
| COAPROVEL Tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| DIOVAN HCT Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| EDARBYCLOR Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| FORTZAAR Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| HYZAAR Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| LOSARB PLUS Film-coated tablet | MPI, EU: PIL | ||
| TOLUCOMBI 40mg/12.5mg / 80mg/12.5mg Tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| TOLUCOMBI 80 mg/25 mg Tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
